Pfizer (PFE) Announces Data Published in NEJM Shows its Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia
Go back to Pfizer (PFE) Announces Data Published in NEJM Shows its Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 PneumoniaPfizer Inc. (NYSE: PFE) | Delayed: 26.25 -0.01 (0.04%) | |||||
---|---|---|---|---|---|---|
Previous Close | $26.26 | 52 Week High | $37.39 | |||
Open | $26.33 | 52 Week Low | $28.25 | |||
Day High | $26.47 | P/E | 15.91 | |||
Day Low | $26.19 | EPS | $1.65 | |||
Volume | 13,762,500 |